Innovative Medicines Canada / Médicaments novateurs Canada: New IMC Report Shows Impact of Chronic Disease and Increased Claims on Private Drug Plans
Innovative Medicines Canada / Médicaments novateurs Canada: New IMC Report Shows Impact of Chronic Disease and Increased Claims on Private Drug Plans 2016-2019 Analysis of Private Drug Claim Cost Drivers report, released today. The report also finds that drug claim costs are rising at approximately 5% annually, less than half of the 11% that insurers have projected. The report demonstrates that the major cost increases to private health benefit plans in Canada are a result of increased drug utilization due to the growth in chronic diseases, like diabetes, requiring access to more medications...
Source: finanznachrichten.de
